Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

AVNEE SHAH

Allopathic & Osteopathic Physicians Dermatology

NPI
1750600656
CMS profile
1293645
Location
WEST ORANGE, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$2,840.82

168 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,190.82 167
Consulting Fee $650.00 1

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 168 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

AVNEE SHAH

NPI 1750600656 · CMS profile ID 1293645

Allopathic & Osteopathic Physicians / Dermatology

WEST ORANGE, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 168 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1750600656?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
AVNEE SHAH, NPI 1750600656, CMS profile ID 1293645. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 168 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1750600656?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). AVNEE SHAH, NPI 1750600656, CMS profile ID 1293645. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 168 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1750600656?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
AVNEE SHAH, NPI 1750600656, CMS profile ID 1293645, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 168 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1750600656?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

168 matching records · $2,840.82 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 168 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 168.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Galderma Laboratories, L.P. $13.3305/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059723477 CMS
Incyte Corporation $9.6705/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044232299 CMS
Journey Medical Corporation $15.1905/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054362529 CMS
E.R. Squibb & Sons, L.L.C. $12.9505/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015705703 CMS
LEO Pharma Inc. $14.9805/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053526927 CMS
Galderma Laboratories, L.P. $14.7304/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059723475 CMS
Amgen Inc. $16.6004/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020541071 CMS
Incyte Corporation $7.6004/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044232251 CMS
Incyte Corporation $8.2804/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044232259 CMS
GENZYME CORPORATION $15.3904/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050259659 CMS
Arcutis Biotherapeutics, Inc. $14.3904/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044654619 CMS
AbbVie Inc. $14.9304/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998926491 CMS
PFIZER INC. $15.3004/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049160462 CMS
Sun Pharmaceutical Industries Inc. $15.8204/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053799095 CMS
Lilly USA, LLC $18.5804/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031270671 CMS
AbbVie Inc. $7.2204/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998926487 CMS
E.R. Squibb & Sons, L.L.C. $14.9004/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015705699 CMS
LEO Pharma Inc. $12.7004/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053526921 CMS
Lilly USA, LLC $16.2404/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031257759 CMS
AbbVie Inc. $12.1503/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998926483 CMS
Arcutis Biotherapeutics, Inc. $12.3103/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044654643 CMS
AbbVie Inc. $9.3303/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998926479 CMS
LEO Pharma Inc. $8.2503/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053526915 CMS
Arcutis Biotherapeutics, Inc. $16.8103/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044654631 CMS
Dermavant Sciences, Inc. $12.8003/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991250441 CMS
AbbVie Inc. $11.6203/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998926475 CMS
AbbVie Inc. $11.2803/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998926471 CMS
E.R. Squibb & Sons, L.L.C. $8.3203/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015705679 CMS
PFIZER INC. $13.8203/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049508623 CMS
E.R. Squibb & Sons, L.L.C. $9.6003/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015705665 CMS
Galderma Laboratories, L.P. $13.7303/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059723473 CMS
PFIZER INC. $16.1003/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049396311 CMS
AbbVie Inc. $9.0003/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998926467 CMS
E.R. Squibb & Sons, L.L.C. $10.9803/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015705669 CMS
Amgen Inc. $16.8502/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020541069 CMS
Galderma Laboratories, L.P. $12.7302/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059723471 CMS
AbbVie Inc. $13.2502/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998926463 CMS
Regeneron Healthcare Solutions, Inc. $14.3302/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999430425 CMS
E.R. Squibb & Sons, L.L.C. $15.2702/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015705655 CMS
E.R. Squibb & Sons, L.L.C. $9.2702/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015705659 CMS
Lilly USA, LLC $17.8502/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031276489 CMS
Dermavant Sciences, Inc. $13.8102/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991250437 CMS
Incyte Corporation $17.2002/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044232211 CMS
E.R. Squibb & Sons, L.L.C. $9.9802/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015705647 CMS
Arcutis Biotherapeutics, Inc. $15.0102/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044654583 CMS
GENZYME CORPORATION $14.9502/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050259609 CMS
AbbVie Inc. $14.0502/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998926459 CMS
Galderma Laboratories, L.P. $14.2702/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059723469 CMS
AbbVie Inc. $0.6702/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998926451 CMS
AbbVie Inc. $12.6802/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998926455 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $648.61 43
PY2020 $539.90 41
PY2021 $746.82 58
PY2022 $1,842.88 150
PY2023 $2,840.82 168
PY2024 $1,700.12 117
PY2025 $2,458.44 136

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $30,416.45 22

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $3,537.36 12/31/2025 Non-covered Recipient Entity
SCHWEIGER DERMATOLOGY PC
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects with Non-Segmental Vitiligo Who Are Eligible for Systemic Therapy No dispute reported 06/30/2026 1202533093
Principal investigator 1 ABBVIE INC. $42.90 12/31/2025 Non-covered Recipient Entity
SCHWEIGER DERMATOLOGY PC
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo (Viti-Up) No dispute reported 06/30/2026 1202535213
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $100.00 12/29/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434277
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $100.00 12/29/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434282
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,200.00 12/24/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434266
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $300.00 12/24/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434269
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $500.00 12/24/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434273
Principal investigator 1 ABBVIE INC. $65.00 12/16/2025 Non-covered Recipient Entity
SCHWEIGER DERMATOLOGY PC
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo (Viti-Up) No dispute reported 06/30/2026 1202530588
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $75.00 12/11/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata No dispute reported 06/30/2026 1252797082
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $2,361.40 12/04/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434259
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $9,760.00 11/24/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata No dispute reported 06/30/2026 1252797080
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $250.00 11/19/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434255
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $61.29 10/30/2025 Non-covered Recipient Entity
Schweiger Dermatology Group
A Phase 3b/4 Multi-center, Randomized, Open-label, Long-term Safety Study of Deucravacitinib in Comparison to Ustekinumab in Participants with Moderate-to-Severe Plaque Psoriasis (PragmaTYK) No dispute reported 06/30/2026 1235993755
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,180.70 10/10/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434252
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,180.70 09/26/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434244
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $500.00 09/02/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434241
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $623.00 08/21/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434236
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $2,609.70 08/20/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434228
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $646.00 08/20/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434232
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,481.00 05/29/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434212
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $2,661.70 04/17/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434207
Principal investigator 1 SUN PHARMACEUTICAL INDUSTRIES INC. $1,180.70 03/24/2025 Non-covered Recipient Entity
Schweiger Dermatology PC
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata No dispute reported 06/30/2026 1246434200